Keyphrases
Squamous Cell Carcinoma (SqCC)
100%
Orbital Exenteration
100%
Cemiplimab
100%
Locally Advanced
60%
Advanced Squamous Cell Carcinoma
60%
Periocular
60%
Orbital Invasion
60%
Overall Response Rate
40%
Myocarditis
20%
Treatment Duration
20%
Treatment Cessation
20%
Further Treatment
20%
Tertiary Care Hospital
20%
Clinical Data
20%
Adverse Events
20%
Demographic Data
20%
Progressive Disease
20%
Programmed Death-ligand 1 (PD-L1)
20%
% Response
20%
Patient with Tumor
20%
Follow-up Time
20%
Proteinase Inhibitor
20%
Partial Response
20%
Biopsy-proven
20%
Creatinine Level
20%
Complete Response
20%
Bullous Dermatoses
20%
Stable Disease
20%
Complete Responders
20%
Eastern Cooperative Oncology Group
20%
Real-world Retrospective Study
20%
Medicine and Dentistry
Squamous Cell Carcinoma
100%
Orbital Exenteration
100%
Cemiplimab
100%
Disease
20%
Biopsy
20%
Myocarditis
20%
Recurrent Disease
20%
Neoplasm
20%
Adverse Event
20%
Oncology
20%
Progressive Disease
20%
Creatinine
20%
Treatment Duration
20%
Retrospective Study
20%
Protein Inhibitor
20%
Programmed Death 1 Receptor
20%
Bullous Dermatitis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Cemiplimab
100%
Disease
40%
Recurrent Disease
20%
Adverse Event
20%
Neoplasm
20%
Creatinine
20%
Retrospective Study
20%
Myocarditis
20%
Programmed Death 1 Receptor
20%
Protein Inhibitor
20%
Bullous Dermatitis
20%